Medicare Enrolled

Dr. Chirag Dalsania, M.D.

Internal Medicine · Oxnard, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1700 N ROSE AVE, Oxnard, CA 93030
8054858709
In practice since 2006 (19 years)
NPI: 1215026380 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dalsania from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dalsania? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dalsania

Dr. Chirag Dalsania is an internal medicine specialist in Oxnard, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dalsania performed 11,129 Medicare services across 3,380 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dalsania received a total of $7,912 from 59 pharmaceutical and/or device companies across 348 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dalsania is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 2% volume in CA $7,912 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,129
Medicare services
Top 2% in CA for internal medicine
3,380
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~586 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
3,604 $8 $18
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
3,479 $8 $30
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,815 $71 $150
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,561 $104 $195
Enhanced Oncology Model monthly payment
This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients.
287 $76 $100
New patient office visit, complex (60-74 min) 177 $180 $375
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
107 $95 $205
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
48 $139 $395
Prothrombin time test (blood clotting)
A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process.
21 $4 $25
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
19 $145 $250
Biopsy of bone marrow 11 $145 $425
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,912
Total received (2018-2024)
Avg $1,130/year across 7 years
Top 12% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
348
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,471 (94.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$441 (5.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,049
2023
$1,903
2022
$1,214
2021
$243
2020
$181
2019
$1,150
2018
$1,171

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$229
Daiichi Sankyo Inc.
$200
Celgene Corporation
$161
EMD Serono, Inc.
$112
ABBVIE INC.
$103
Novartis Pharmaceuticals Corporation
$97
Genentech USA, Inc.
$96
GlaxoSmithKline, LLC.
$83
Merck Sharp & Dohme LLC
$81
AstraZeneca Pharmaceuticals LP
$76
Exelixis Inc.
$70
Regeneron Healthcare Solutions, Inc.
$68
Karyopharm Therapeutics Inc.
$66
E.R. Squibb & Sons, L.L.C.
$59
Gilead Sciences, Inc.
$58
Janssen Biotech, Inc.
$57
Alexion Pharmaceuticals, Inc.
$52
Eisai Inc.
$48
Astellas Pharma US Inc
$45
Stemline Therapeutics Inc.
$43
JAZZ PHARMACEUTICALS INC.
$36
PharmaEssentia USA Corporation
$32
GENZYME CORPORATION
$31
Tempus AI, Inc
$29
Ipsen Biopharmaceuticals, Inc
$28
ImmunoGen, Inc.
$27
Agios Pharmaceuticals, Inc.
$23
PUMA BIOTECHNOLOGY, INC.
$19
SERVIER PHARMACEUTICALS LLC
$19
Top 3 companies account for 28.8% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$570
PFIZER INC.
$566
Novartis Pharmaceuticals Corporation
$509
Celgene Corporation
$426
E.R. Squibb & Sons, L.L.C.
$309
Daiichi Sankyo Inc.
$306
Alexion Pharmaceuticals, Inc.
$298
Merck Sharp & Dohme LLC
$281
AstraZeneca Pharmaceuticals LP
$277
ADC Therapeutics America, Inc.
$262
Pharmacyclics LLC, An AbbVie Company
$255
Janssen Biotech, Inc.
$252
Astellas Pharma US Inc
$248
Merck Sharp & Dohme Corporation
$216
Gilead Sciences, Inc.
$214
Exelixis Inc.
$171
EMD Serono, Inc.
$157
GlaxoSmithKline, LLC.
$152
Eisai Inc.
$144
Array BioPharma Inc.
$141
Karyopharm Therapeutics Inc.
$133
Amgen Inc.
$129
EISAI INC.
$128
Kite Pharma, Inc.
$122
ABBVIE INC.
$116
GE HealthCare
$103
Regeneron Healthcare Solutions, Inc.
$100
Foundation Medicine, Inc.
$88
GENZYME CORPORATION
$88
BeiGene USA, Inc.
$85
Seagen Inc.
$79
Incyte Corporation
$74
TESARO, Inc.
$69
Seattle Genetics, Inc.
$60
AbbVie Inc.
$53
PharmaEssentia USA Corporation
$50
Deciphera Pharmaceuticals Inc.
$49
Spectrum Pharmaceuticals Inc.
$45
ImmunoGen, Inc.
$45
Stemline Therapeutics Inc.
$43
SERVIER PHARMACEUTICALS LLC
$37
JAZZ PHARMACEUTICALS INC.
$36
PUMA BIOTECHNOLOGY, INC.
$35
Lilly USA, LLC
$34
Takeda Pharmaceuticals U.S.A., Inc.
$33
Puma Biotechnology, Inc.
$30
Tempus AI, Inc
$29
MEDIVATION FIELD SOLUTIONS LLC
$29
Rigel Pharmaceuticals, Inc.
$29
Ipsen Biopharmaceuticals, Inc
$28
Myriad Genetic Laboratories, Inc.
$26
SANOFI-AVENTIS U.S. LLC
$24
Agios Pharmaceuticals, Inc.
$23
Taiho Oncology, Inc.
$21
AbbVie, Inc.
$17
Dendreon Pharmaceuticals LLC
$17
SOBI, INC
$16
ACCORD HEALTHCARE, INC.
$16
TOLMAR Pharmaceuticals, Inc.
$16
Top 3 companies account for 20.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · Abraxane · Alecensa · Avastin · BAVENCIO · BESREMI · BOSULIF · BRUKINSA · Braftovi · CABOMETYX · CALQUENCE · CAMCEVI · DARZALEX · Doptelet · ELAHERE · ELIGARD · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · EVENITY · Elahere · Enhertu · Erleada · FOUNDATIONONE · Fabhalta · Folotyn · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · LIBTAYO · LORBRENA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · NERLYNX · Neulasta · Nplate · OJJAARA · OPDIVO · OPDUALAG · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PREVNAR 20 · PROMACTA · PROVENGE · PYRUKYND · Perjeta · Polivy · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · SARCLISA · SHINGRIX · SUTENT · TAGRISSO · TALZENNA · TASIGNA · TECENTRIQ · TIVDAK · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · XALKORI · XPOVIO · XTANDI · Xtandi · ZEJULA · ZEPZELCA · ZYTIGA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an internal medicine specialist in Oxnard?
Compare internal medicine physicians in the Oxnard area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
305
Per 100K population
36.4
County median income
$107,327
Nearest hospital
ST JOHNS REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dalsania is a clinical cardiology specialist, with above-average Medicare volume (top 2% in CA), with low-engagement industry engagement in the top 12% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Dalsania experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Dalsania performed 3,604 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dalsania receive payments from pharmaceutical companies?
Yes. Dr. Dalsania received a total of $7,912 from 59 companies across 348 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dalsania's costs compare to other internal medicine physicians in Oxnard?
Dr. Dalsania's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dalsania) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →